Welcome to LookChem.com Sign In|Join Free
  • or
4,5-Dimethoxy-2-(2-propenyl)phenol, commonly known as eugenol, is a naturally occurring chemical compound found in a variety of plants such as clove, basil, and cinnamon. It is characterized by its pleasant aroma and flavor, which makes it a popular ingredient in the production of perfumes, flavorings, and essential oils. Eugenol also exhibits antimicrobial and antioxidant properties, contributing to its wide range of applications in various industries.

59893-87-7

Post Buying Request

59893-87-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

59893-87-7 Usage

Uses

Used in Flavor and Fragrance Industry:
4,5-Dimethoxy-2-(2-propenyl)phenol is used as a flavoring agent for its distinctive taste and as a fragrance component for its pleasant aroma in various consumer products such as food, beverages, and cosmetics.
Used in Dental Products:
In the dental industry, 4,5-Dimethoxy-2-(2-propenyl)phenol is used as an antimicrobial agent to prevent the growth of bacteria in mouthwashes and toothpastes, contributing to better oral hygiene and reducing the risk of dental caries.
Used as a Natural Preservative:
4,5-Dimethoxy-2-(2-propenyl)phenol is utilized as a natural preservative in food and beverage products due to its ability to inhibit the growth of spoilage-causing microorganisms, thus extending the shelf life of these products.
Used in Traditional Medicine:
In traditional medicine, 4,5-Dimethoxy-2-(2-propenyl)phenol is used for its potential anti-inflammatory and analgesic effects, making it a valuable component in treatments for pain and inflammation.
Used in Pharmaceutical Industry:
4,5-Dimethoxy-2-(2-propenyl)phenol is employed in the pharmaceutical industry for its potential therapeutic applications, including its use in pain management and anti-inflammatory medications.
Used in Antioxidant Formulations:
Due to its antioxidant properties, 4,5-Dimethoxy-2-(2-propenyl)phenol is used in various formulations to protect against oxidative stress and free radical damage, which can be beneficial in skincare and health supplement products.
Used in Research and Development:
4,5-Dimethoxy-2-(2-propenyl)phenol is also used in research settings to study its potential applications in various fields, such as its antimicrobial, antioxidant, anti-inflammatory, and analgesic properties, as well as its potential use in drug delivery systems and other innovative applications.

Check Digit Verification of cas no

The CAS Registry Mumber 59893-87-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,9,8,9 and 3 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 59893-87:
(7*5)+(6*9)+(5*8)+(4*9)+(3*3)+(2*8)+(1*7)=197
197 % 10 = 7
So 59893-87-7 is a valid CAS Registry Number.

59893-87-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 4,5-dimethoxy-2-prop-2-enylphenol

1.2 Other means of identification

Product number -
Other names 6-Allyl-3,4-dimethoxyphenol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:59893-87-7 SDS

59893-87-7Relevant academic research and scientific papers

NEOLIGNANS FROM ANIBA LANCIFOLIA

Diaz D., Pedro, P.,Yoshida, Massayoshi,Gottlieb, Otto R.

, p. 285 - 288 (1980)

The branches of the shrub Aniba lancifolia Kubitzki et Rodrigues (Lauraceae) contain besides 2-hydroxy-4,5-dimethoxyallylbenzene and its dimer cyclohexan-2-allyl-5-en-4,5-dimethoxy-4-O-(2'-allyl-4;,5'-dimethoxyphenyl)-1-one (lancilin, 2) 6 further novel n

Investigating the microwave-accelerated Claisen rearrangement of allyl aryl ethers: Scope of the catalysts, solvents, temperatures, and substrates

Hui, Zi,Jiang, Songwei,Qi, Xiang,Ye, Xiang-Yang,Xie, Tian

supporting information, (2020/05/18)

The microwave-accelerated Claisen rearrangement of allyl aryl ethers was investigated, in order to gain insight into the scope of the catalysts, solvents, temperatures, and substrates. Among the catalysts examined, phosphomolybdic acid (PMA) was found to greatly accelerate the reaction in NMP, at temperatures ranging from 220 to 300 °C. This method was found to be useful for preparing several intermediates previously reported in the literature using precious metal catalysts such as Au(I), Ag(I), and Pt(II). Additionally, substrates bearing bromo and nitro groups on the aryl portion required careful tailoring of the reaction conditions to avoid complex product profiles.

Total synthesis of (-)-Haouamine B pentaacetate and structural revision of haouamine B

Momoi, Yuichi,Okuyama, Kei-Ichiro,Toya, Hiroki,Sugimoto, Kenji,Okano, Kentaro,Tokuyama, Hidetoshi

supporting information, p. 13215 - 13219 (2015/01/09)

The enantiocontrolled total synthesis of (-)-haouamine B pentaacetate was accomplished via an optically active indane-fused β-lactam, which was prepared by a newly developed Friedel-Crafts reaction. Subsequent cleavage of the β-lactam and an intramolecular McMurry coupling reaction provided the core indane-fused tetrahydropyridine, which led to the elucidation of the structure, as proposed by Trauner and Zuba.

Metabolism of methylisoeugenol in liver microsomes of human, rat, and bovine origin

Cartus, Alexander T.,Merz, Karl-Heinz,Schrenk, Dieter

experimental part, p. 1727 - 1733 (2012/03/22)

Methylisoeugenol (1,2-dimethoxy-4-propenylbenzene, 1) is a minor constituent of essential oils, naturally occurring as a mixture of cis/trans isomers. 1 is a U.S. Food and Drug Administration-approved food additive and has been given "Generally Recognized as Safe" status. Previously, metabolism of 1 has been studied in the rat, revealing mainly nontoxic cinnamoyl derivatives as major metabolites. However, data concerning the possible formation of reactive intermediary metabolites are not available to date. In this study, the oxidative metabolism of 1 was studied using liver microsomes of rat [not induced, rat liver microsomes (RLM); Aroclor1254 induced RLM (ARLM)], bovine, and human (pooled from 150 donors) origin. Incubations of these microsomes with 1 provided phase I metabolites that were separated by high-performance liquid chromatography (HPLC) and identified by NMR and UV-visible spectroscopy and/or liquid chromatography-mass spectrometry. Identity was confirmed by comparison with 1H NMR spectra of synthesized reference compounds. Formation of metabolites was quantified by HPLC/UV using dihydromethyleugenol (10) synthesized as the internal standard. From incubations of ARLM with 1, seven metabolites could be detected, with 3′- hydroxymethylisoeugenol (2), isoeugenol and isochavibetol (3 + 4), and 6-hydroxymethylisoeugenol (5) being the main metabolites. Secondary metabolites derived from 1 were identified as the α,β-unsaturated aldehyde 3′-oxomethylisoeugenol (6) and 1′,2′-dihydroxy- dihydromethylisoeugenol (7). We were surprised to find that formation of allylic 6-hydroxymethyleugenol (8) was observed starting at approximately 30 min after the beginning of incubations with ARLM. HLM did not form ring-hydroxylated metabolites but were most active in the formation of 6 and 7. ARLM incubations displayed the highest turnover rate and broadest metabolic pattern, presumably resulting from an increased expression of cytochrome P450 enzymes. In conclusion, we present a virtually complete pattern of nonconjugated microsomal metabolites of 1 comprising reactive metabolites and suggest the formation of reactive intermediates that need more investigation with respect to their possible adverse properties. Copyright

Design, synthesis, and docking of highly hypolipidemic agents: Schizosaccharomyces pombe as a new model for evaluating α-asarone-based HMG-CoA reductase inhibitors

Argueelles, Nancy,Sanchez-Sandoval, Eugenia,Mendieta, Aaron,Villa-Tanaca, Lourdes,Garduno-Siciliano, Leticia,Jimenez, Fabiola,Cruz, Maria del Carmen,Medina-Franco, Jose L.,Chamorro-Cevallos, German,Tamariz, Joaquin

experimental part, p. 4238 - 4248 (2010/09/12)

A series of α-asarone-based analogues was designed by conducting docking experiments with published crystal structures of human HMG-CoA reductase. Indeed, synthesis and evaluation of this series showed a highly hypocholesterolemic in vivo activity in a murine model, as predicted by previous docking studies. In agreement with this model, the polar groups attached to the benzene ring could play a key role in the enzyme binding and probably also in its biological activity, mimicking the HMG-moiety of the natural substrate. The hypolipidemic action mechanism of these compounds was investigated by developing a simple, efficient, and novel model for determining HMG-CoA reductase inhibition. The partial purification of the enzyme from Schizosaccharomyces pombe allowed for testing of α-asarone- and fibrate-based analogues, resulting in positive and significant inhibitory activity.

Ring-closing metathesis for the synthesis of 2H- and 4H-chromenes

Van Otterlo, Willem A.L.,Ngidi, E. Lindani,Kuzvidza, Samuel,Morgans, Garreth L.,Moleele, Simon S.,De Koning, Charles B.

, p. 9996 - 10006 (2007/10/03)

Six 4H-chromenes were synthesized from substituted phenols using vinylstannylation and ring-closing metathesis (RCM) as key steps. In addition, a different approach involving amongst other steps, an aryl allyl isomerization and RCM afforded a set of seven 2H-chromenes from phenolic precursors.

Ring-closing metathesis for the synthesis of benzo-fused bicyclic compounds

Van Otterlo, Willem A.L.,Ngidi, E. Lindani,Coyanis, E. Mabel,De Koning, Charles B.

, p. 311 - 313 (2007/10/03)

Ring-closing metathesis (RCM) was used to synthesise five 4H-chromenes, a naphthol and an indenol. These are the first examples of RCM applied to the synthesis of such benzo-fused bicyclic compounds.

A biomimetic approach to dihydrobenzofuran synthesis

Benbow,Katoch-Rouse

, p. 4965 - 4972 (2007/10/03)

A method for an acid-catalyzed construction of dihydrobenzofuran heterocycles (14) from 2-(2′-hydroxyethyl)quinone precursors 10 is presented. The putative oxonium ion intermediate 17 formed by an intramolecular hydroxyl cyclization followed by dehydration is reduced in situ by an added dihydroquinone source. Good to excellent yields of cyclized products are realized in all cases except for highly electron deficient systems, and these suffer reduction prior to oxonium ion formation. All products are monomeric and derived from a two-electron transfer except for 10g, which affords the dimeric dihydrobenzofuran. The amount of cyclization or reduction product is governed by the HOMO/LUMO gap between the quinone substrate and the dihydroquinone additive, and the product distribution can be adjusted by modifying the electronic properties of the added reducing agent.

The Synthesis of Megaphone

Buechi, George,Chu, Ping-Sun

, p. 2718 - 2721 (2007/10/02)

Condensation of 4,4,5-trimethoxy-2-propyl>-2,5-cyclohexadien-1-one (7) with 1,2,3-trimethoxy-5-(1-(Z)-propenyl)benzene in dichloromethane, in the presence of 1 equiv. of stannic chloride, gave (2β,3β,3aα)-3,3a-dihydro-5-methoxy-3-m

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 59893-87-7